Michael Golembiewski
2023
In 2023, Michael Golembiewski earned a total compensation of $846.7K as Chief Financial Officer at Apricus Biosciences, a 21% decrease compared to previous year.
Compensation breakdown
| Option Awards | $458,467 |
|---|---|
| Salary | $375,000 |
| Other | $13,200 |
| Total | $846,667 |
Golembiewski received $458.5K in option awards, accounting for 54% of the total pay in 2023.
Golembiewski also received $375K in salary and $13.2K in other compensation.
Rankings
In 2023, Michael Golembiewski's compensation ranked 1,380th out of 2,918 executives tracked by ExecPay. In other words, Golembiewski earned more than 52.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,380 out of 2,918 | 53rd |
Division Manufacturing | 827 out of 1,608 | 49th |
Major group Chemicals And Allied Products | 541 out of 901 | 40th |
Industry group Drugs | 528 out of 864 | 39th |
Industry Pharmaceutical Preparations | 369 out of 622 | 41st |
Source: SEC filing on August 20, 2024.
Golembiewski's colleagues
We found one more compensation record of an executive who worked with Michael Golembiewski at Apricus Biosciences in 2023.
2023
Raj Mehra
Apricus Biosciences